Versartis, Inc.
 (VSAR)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Oct. 29, 2015, 5:19 PM
    • Versartis (NASDAQ:VSAR): Q3 EPS of -$0.69 beats by $0.02.
    • PR
    | Oct. 29, 2015, 5:19 PM
  • Aug. 4, 2015, 8:35 AM
    • Versartis (NASDAQ:VSAR): Q2 EPS of -$0.67 misses by $0.03.
    | Aug. 4, 2015, 8:35 AM
  • May 6, 2015, 6:06 PM
    • Versartis (NASDAQ:VSAR): Q1 EPS of -$0.79 misses by $0.16.
    | May 6, 2015, 6:06 PM
  • Feb. 12, 2015, 5:05 PM
    • Versartis (NASDAQ:VSAR): Q4 EPS of -$0.65 misses by $0.21.
    | Feb. 12, 2015, 5:05 PM
  • Nov. 6, 2014, 6:07 PM
    • Versartis (NASDAQ:VSAR): Q3 EPS of -$0.57 misses by $0.04.
    | Nov. 6, 2014, 6:07 PM
  • Aug. 5, 2014, 6:15 PM
    • Versartis (NASDAQ:VSAR): Q2 EPS of -$0.36 beats by $0.09.
    | Aug. 5, 2014, 6:15 PM
  • Aug. 5, 2014, 4:40 PM
    • Versartis (VSAR -4%) Q2 results: Revenues: $0; Operating Expenses: $8.5M (+113.4%); Operating Loss: ($8.5M) (-113.4%); Net Loss: ($8.6M) (-135.3%); Loss Per Share: ($0.36) (+98.5%); Quick Assets: $192.8M (+999%).
    • No guidance given.
    | Aug. 5, 2014, 4:40 PM
Company Description
Versartis Inc is a development stage biopharmaceutical company developing therapeutic proteins for the treatment of metabolic diseases and endocrine disorders.
Sector: Healthcare
Industry: Drugs - Generic
Country: United States